Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics™
COVID Central
Rewinds
Click for the Rewinds Archive
Write for Us
Writer Application
Submit an Opinion
Subscribe
For Partners
License Content
Submit Press Release
Advertise with Us
Account
Register
Sign-In
Manage Subscriptions
Search
Wednesday, February 24, 2021
About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Pulmonary arterial pruning and longitudinal change in percent emphysema and lung…
Azithromycin does not reduce mortality in patients hospitalized with COVID-19
Antibiotic prophylaxis for UTIs in elderly patients associated with an increased…
Limiting On-Call Hours Improves Resident-Physicians’ Neurobehavioral Performance
Classics™
COVID Central
Rewinds
2 Minute Medicine Rewind February 22, 2021
2 Minute Medicine Rewind February 8, 2021
2 Minute Medicine Rewind Jan 25, 2021
2 Minute Medicine Rewind January 25, 2021
2 Minute Medicine Rewind January 18, 2021
Click for the Rewinds Archive
Write for Us
Writer Application
Submit an Opinion
Subscribe
For Partners
License Content
Submit Press Release
Advertise with Us
Account
Register
Sign-In
Manage Subscriptions
Tag: blood cancer
#VisualAbstract Phase I: Adding carfilzomib to HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia showed favourable safety and efficacy outcomes
Kathleen Lau
-
February 19, 2021
0
Read more
#VisualAbstract Bortezomib, cyclophosphamide, and dexamethasone demonstrated a modest median event-free survival in transplant ineligible patients with multiple myeloma
Kathleen Lau
-
February 18, 2021
0
Read more
#VisualAbstract Low-PV study: Adding ropeginterferon alfa-2b to phlebotomy and aspirin shows improvement in response rates for treatment of polycythaemia vera in low-risk patients
Kathleen Lau
-
February 12, 2021
0
Read more
#VisualAbstract Multiple Cereblon genetic alterations were associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma
Kathleen Lau
-
February 11, 2021
0
Read more
Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma
Kathleen Lau
-
February 5, 2021
0
Read more
#VisualAbstract ENESTnd: Frontline nilotinib therapy shows improvement in long-term efficacy outcomes for patients in the chronic phase of newly diagnosed chronic myeloid leukemia
Kathleen Lau
-
February 4, 2021
0
Read more
#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis
Kathleen Lau
-
January 29, 2021
0
Read more
#VisualAbstract Lenalidomide shows improvement in progression-free survival over bortezomib maintenance following autologous stem cell transplantation for multiple myeloma
Kathleen Lau
-
January 28, 2021
0
Read more
#VisualAbstract Oral poly(ADP-ribose) polymerase inhibitors were associated with an increased risk of myelodysplastic syndrome and acute myeloid leukaemia over placebo treatment in patients with cancer
Kathleen Lau
-
January 22, 2021
0
Read more
#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants
Kathleen Lau
-
January 21, 2021
0
Read more
1
2
3
Page 1 of 3